Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


Association between birth order and emergency room visits and acute hospital admissions following pediatric vaccination: a self-controlled study.

Hawken S, Kwong JC, Deeks SL, Crowcroft NS, Ducharme R, Manuel DG, Wilson K.

PLoS One. 2013 Dec 4;8(12):e81070. doi: 10.1371/journal.pone.0081070. eCollection 2013.


Seasonal variation in rates of emergency room visits and acute admissions following recommended infant vaccinations in Ontario, Canada: a self-controlled case series analysis.

Hawken S, Potter BK, Benchimol EI, Little J, Ducharme R, Wilson K.

Vaccine. 2014 Dec 12;32(52):7148-53. doi: 10.1016/j.vaccine.2014.09.059. Epub 2014 Nov 1.


Increased emergency room visits or hospital admissions in females after 12-month MMR vaccination, but no difference after vaccinations given at a younger age.

Wilson K, Ducharme R, Ward B, Hawken S.

Vaccine. 2014 Feb 26;32(10):1153-9. doi: 10.1016/j.vaccine.2014.01.010. Epub 2014 Jan 15.


Underestimating the safety benefits of a new vaccine: the impact of acellular pertussis vaccine versus whole-cell pertussis vaccine on health services utilization.

Hawken S, Manuel DG, Deeks SL, Kwong JC, Crowcroft NS, Wilson K.

Am J Epidemiol. 2012 Dec 1;176(11):1035-42. doi: 10.1093/aje/kws167. Epub 2012 Nov 1.


Impact of birth weight at term on rates of emergency room visits and hospital admissions following vaccination at 2 months of age.

Wilson K, Hawken S, Kwong JC, Deeks SL, Manuel DG, Henningsen KH, Crowcroft NS.

Vaccine. 2011 Oct 26;29(46):8267-74. doi: 10.1016/j.vaccine.2011.08.107. Epub 2011 Sep 9.


Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis.

Wilson K, Hawken S, Kwong JC, Deeks S, Crowcroft NS, Van Walraven C, Potter BK, Chakraborty P, Keelan J, Pluscauskas M, Manuel D.

PLoS One. 2011;6(12):e27897. doi: 10.1371/journal.pone.0027897. Epub 2011 Dec 12.


Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial.

Langley JM, Halperin SA, Rubin E, White C, McNeil S, Mutch J, Mackinnon-Cameron D, Smith B.

Pediatr Infect Dis J. 2012 Feb;31(2):189-92. doi: 10.1097/INF.0b013e318242462a.


Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.

Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.


Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.

Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S; Canadian Paediatric Society/ Health Canada Immunization Monitoring Program-Active (IMPACT).

Pediatrics. 2003 Nov;112(5):e348.


Association between socioeconomic status and adverse events following immunization at 2, 4, 6 and 12 months.

Wilson K, Ducharme R, Hawken S.

Hum Vaccin Immunother. 2013 May;9(5):1153-7. doi: 10.4161/hv.23533. Epub 2013 Jan 17.


Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.

Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D; HibMenCY-TT 005 Study Group.

Pediatr Infect Dis J. 2010 Jan;29(1):48-52. doi: 10.1097/INF.0b013e3181c3ce88.


Nicolau syndrome may be caused by intravascular vaccine injection.

Bégin P, Anne DR.

Vaccine. 2012 Mar 2;30(11):2035-6. doi: 10.1016/j.vaccine.2011.10.107. Epub 2011 Dec 22. No abstract available.


Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.

Halperin SA, Langley JM, Hesley TM, Zappacosta PS, Radley D, Smith B, Hoffenbach A, Boslego J, Silber JL.

Hum Vaccin. 2005 Nov-Dec;1(6):245-50. Epub 2005 Nov 17.


Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.

Diaz-Mitoma F, Halperin SA, Tapiero B, Hoffenbach A, Zappacosta PS, Radley D, Bradshaw S, Martin JC, Boslego JW, Hesley TM, Bhuyan PK, Silber JL.

Vaccine. 2011 Feb 1;29(6):1324-31. doi: 10.1016/j.vaccine.2010.11.053. Epub 2010 Dec 4.


Supplemental Content

Support Center